To get a more detailed quote on a company, go to our stock quote page.
 |
Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0)Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by |
 |
Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0)One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact. |
 |
Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0)Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing |
 |
Men’s Health Features Naked Brand Group Line of Underwear(0)Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.” The guide was published on MensHealth.com on March 20. This is the second time the company has been featured in the men’s mag in as |
 |
Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0)Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General |
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.
Contacts and informationHave an opinion or news that you want to share?
|
Social networks |
Most popular categories |
0 comments
Add your comment
Commenting is allowed only for registered users.